CEO Biotechnology Cancer Research
Open to offersNew to PlatformRaashika A. is a South Africa-based Chief Executive Officer specializing in oncology biotechnology. With an academic foundation in Genetics and Developmental Biology, Raashika graduated Cum Laude from the University of the Witwatersrand. Leading Oncogenexe Biotech Pty Ltd, she steers groundbreaking therapeutic innovations for cancer treatment, advancing research with Next Generation Sequencing and clinical trials across Southern Africa. Previously serving as Chief Scientific Officer at Bionuclex Research Pty Ltd, Raashika was pivotal in designing early disease detection protocols, leveraging platforms like Illumina and Oxford Nanopore Technologies. She brings extensive expertise in regulatory strategy and trial management from roles at African Clinical Research Organization and BARC South Africa PTI, where she directed numerous oncology-focused studies and maintained rigorous compliance with global health authorities. Raashika's career is marked by her contributions to proteomics and bioinformatics, ensuring precision in antibody isolation and data privacy through quantum computing.